Search Login Register

Neoplasms (Cancer) Summary

415397 relevant articles (20112 outcomes, 52155 trials/studies) found for this Disease

Description: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Also Known As: Cancer; Tumor; Tumors; Cancers; Neoplasm Show All >>

Key Drugs and Agents for Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antigens : 554 outcomes 1675 studies in 18544 results : IBA
  2. Cisplatin (Platino) : 534 outcomes 992 studies in 5825 results : FDA 6 Generic
  3. DNA (Deoxyribonucleic Acid) : 424 outcomes 1760 studies in 20047 results : IBA
  4. Doxorubicin (Adriamycin) : 383 outcomes 564 studies in 4316 results : FDA 12 Generic
  5. Interleukin-2 (IL2) : 343 outcomes 582 studies in 3938 results : IBA
  6. Fluorouracil (Carac) : 312 outcomes 673 studies in 4039 results : FDA 32 Generic
  7. Paclitaxel (Taxol) : 270 outcomes 627 studies in 2685 results : FDA 12 Generic
  8. Hormones : 262 outcomes 913 studies in 8463 results : IBA
  9. Antibodies : 244 outcomes 688 studies in 7356 results : IBA
  10. Estrogens (Estrogen) : 224 outcomes 625 studies in 7431 results : FDA 1
Show All >>

Diseases Related to Neoplasms

  1. Neoplasms (Cancer)
  2. Neoplasm Metastasis (Metastasis)
  3. Carcinoma (Carcinomatosis)
  4. Pain (Aches)
  5. Breast Neoplasms (Breast Cancer)
Show All >>

Key Therapies for Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2737 outcomes 3898 studies in 35002 results
  2. Immunotherapy : 601 outcomes 880 studies in 7839 results
  3. Heterologous Transplantation (Xenotransplantation) : 593 outcomes 1068 studies in 8240 results
  4. Aftercare (After-Treatment) : 181 outcomes 227 studies in 3641 results
  5. Transplants (Transplant) : 169 outcomes 308 studies in 4543 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.